Abbreviations: ANOVA ϭ analysis of variance; Fio 2 ϭ fraction of inspired oxygen; f/Vt ϭ rapid shallow breathing index; MH ϭ manual hyperinflation; OR ϭ odds ratio; Pimax ϭ maximal inspiratory pressure; Vt ϭ tidal volume
M
echanical ventilation is indicated in acute reversible respiratory failure. However, patients receiving mechanical ventilation may have an increased risk of sputum retention, atelectasis, and pneumonia, 1,2 making ventilation weaning more difficult 3 and resulting in excess morbidity and mortality. The cost of maintaining patients on prolonged ventilation in the ICUs of acute care hospitals are high. 4 Thus, every effort should be made to determine which patients can be rapidly extubated so as to keep the weaning period to a minimum. Previous evidence suggests that manual hyperinflation (MH) can mobilize pulmonary secretions, reverse atelectatic alveoli, and increase alveolar oxygenation. Many clinical studies have reported the short-term benefits of MH on sputum clearance, 3, 5 reexpansion of atelectasis, [5] [6] [7] [8] improvement of dynamic compliance, 9 and oxygenation. 10 -12 However, the lack of standardized methods for the delivery of MH makes the synthesis and interpretation of the findings difficult. The variability in the types of MH circuit (selfinflating manual resuscitation bags vs oxygen-powered, manual resuscitation bags), the method of MH delivery (technique of pausing at full inspiration vs pressing half of the resuscitator), and the variability in the dosage of MH (ie, duration) all point toward the need for further development of the knowledge base in order to guide best practice.
Manual hyperinflation is defined as inflating the lungs using oxygen and manual compression to provide a tidal volume (Vt) exceeding baseline Vt, and using a Vt that is 50% greater than that delivered by the ventilator, requiring a peak inspiratory pressure of from 20 to 40 cm H 2 O. 13 Four factors are considered important in performing the MH technique: the application of larger-than-normal Vt breaths, 14, 15 use of a slow inspiratory flow rate, 16, 17 an inspiratory pause, 18, 19 and a pressure manometer. 20, 21 In addition, the quick release of pressure on expiration leading to a rapid flow of air can simulate the effect of a cough. 11, 22, 23 Even though no comprehensive studies have been done that incorporate and evaluate all four of the important MH techniques, there is support from clinical and research literature on the theoretical foundations and effectiveness of each of the factors separately. First, the use of larger-than-normal Vt is based on the hypothesis that by delivering a largervolume breath over time, MH may increase the expiratory flow rate and assist in moving secretions toward more proximal airways, where they can be cleared by suctioning. 24 Second, the rate of inflation of the lung as a whole is a function of inflation pressure, compliance, and airway resistance. Nunn 25 described the response to passive inflation of the lungs by the development of a constant airway pressure. If a constant inflation pressure is maintained, an alveolus with half the compliance but twice the resistance of another alveolus will increase in volume by half the volume change of the other alveolus. Thus, the relative distribution of gas between the two alveoli is independent of the rate or duration of inflation. In addition, using both hands to compress the bag can produce a Vt that is 50% greater than that delivered by the ventilator. 26 Furthermore, the rate at which the bag is compressed, rather than the resistance of the circuit itself, is the main influence on the peak inspiratory flow rate. 16, 17, 27 A fast inflation rate that does not allow the reservoir bag to fill adequately, and reduces the fraction of the inspired oxygen (Fio 2 ). 28, 29 Moreover, delivering an increased Vt via MH may generate adequate transpulmonary pressure gradients to overcome alveolar atelectasis. Atelectatic alveoli do not reexpand immediately when the ventilator cycles with the inspiratory phase because a variable period of time is required before the alveolar critical opening pressure is reached. 30 Therefore, the third important factor, the use of an inspiratory hold during MH, is thought to maintain these pressure gradients for an appropriate length of time. This technique may influence the distribution of the ventilation 25 and allow time for alveolar inflation or enlargement, as well as the recruitment or unfolding of interdependent atelectatic alveoli. Finally, a pressure manometer can improve the performance of MH and optimize both the safety and the effectiveness of the treatment. 31 Although there is no consensus about specific safe upper limits for peak airway pressure, barotraumas manifest at peak airway pressures of 26 to 64 cm H 2 O as demonstrated by several animal studies. 20 Therefore, it is reasonable and prudent to minimize the peak airway pressure as much as possible during MH or any other ventilatory support procedure. 32 This study examines the effect of MH in patients with atelectasis associated with ventilation support. The foundation for the practice of MH in this study is based on the best evidence available from clinical and research literature, and incorporates all four factors of MH technique considered to be important, as described above. The hypothesis of this study is that those in the experimental group should have improved sputum contents (wet/dry weight ratio, viscosity), respiratory system capacity (spontaneous Vt), maximal inspiratory pressure (Pimax), an improved rapid shallow breathing index (f/Vt), as well as improved chest radiograph signs and oxygenation ratio (Pao 2 /Fio 2 ).
Materials and Methods

Patient Selection
Thirty-three patients with atelectasis due to ventilatory support were recruited at the pulmonary ICUs from two hospitals; of these 33 patients, 23 completed all of the study procedures. This study was a two-group, prospective, randomized study lasting 6 days. Patients were assigned to one of two groups: standard care with supplemental MH (experimental group, n ϭ 10) or standard care only (control group, n ϭ 13). The Institutional Ethical Committee approved the study protocol, and all patients gave informed written consent. The inclusion criteria consisted of the following: age Ն 40 years; ventilation support Ͼ 7 days and a positive end-expiratory pressure from 6 to 8 cm H 2 O; pulmonary atelectasis; excessive secretions (Ͼ 30 mL/d); and spontaneous Vt Ͻ 250 mL and/or Pimax Ͻ 25 cm H 2 O and/or Vt Ͻ 400 mL under ventilator assistance. Pulmonary atelectasis was diagnosed using the following: (1) chest radiography showing increased infiltration, and (2) physical examination revealing weakness or muteness of the sounds in the involved area. The structural changes that develop in atelectasis increase the density of the lungs. The increase in lung density resists radiograph penetration and is revealed on radiograph films as increased opacity (ie, whiter in appearance). Thus, the more severe the atelectasis, the denser the lungs, and the whiter the radiograph film. Patients were assessed clinically and with a chest radiograph at recruitment to ensure the absence of a Fio 2 Ն 0.6 requirement, pulmonary pathology (for example, ARDS), active infection, acute cardiovascular dysfunction, or other systemic diseases. The trial took place between January 2001 and June 2001. There were three different types of ventilation systems used throughout this study (models 7200, 740, or 760; Nellcor Puritan Bennett; Temecula, CA).
Standard Care
All subjects were asked to continue any current prescribed medication (such as anticholinergic inhaled agents, inhaled corticosteroids, theophylline, prednisolone, or erythromycin) and chest physiotherapy (such as chest percussion, positioning, and suction) throughout the experiment. For the control group, these were the only prescribed treatments. None of the subjects received any sedation or narcotics.
MH
To ensure that uniform and correct techniques were employed, MH was administered by only one investigator. A 2.0-L reusable manual resuscitator (model 2153 MR100 plus; Galemed Corporation; Taipei, Taiwan) was used to deliver the MH breaths, and was connected to a flow of 100% oxygen at 15 L/min (calibrated with an oxygen analyzer). A force meter (Inspiratory Force Meter; Boehringer Laboratories; Norristown, PA) was connected between the resuscitator and the patient. Patients received MH to a peak airway pressure of 20 cm H 2 O by use of the resuscitator. The resuscitator was slowly compressed with both hands, and an inspiratory breath was maintained for 3 to 5 s at the end of pressing half of the resuscitator, and then completely pressing the resuscitator. Expiration was passive and unobstructed to facilitate expiratory flow with no positive end-expiratory pressure applied. Sufficient time was allowed for the resuscitator to fill completely prior to the next breath. Airway suctioning of the endotracheal tube was performed using size 14 catheters (Pahsco; Pacific Hospital Supply; Taipei, Taiwan) at the end of the MH procedure. The MH procedure was carried out at a rate of 8 to 13 breaths/min for a period of 20 min for each session tid (at 7:40 am, 11:40 am, and 3:40 pm) for 5 days on days 1 to 5 of the study.
Sputum Sampling
Nurses were instructed to collect and record the total amount of daily sputum (milliliters per 24 h) throughout the study. An aliquot of sputum from each patient's total amount of daily sputum was freeze-dried (at -80°C, at a negative pressure of 40 cm H 2 O) overnight to measure the wet/dry weight ratio.
The viscosity of the sputum was measured using a viscometer at room temperature (25°C) with distilled water as a control, using sputum sampled by nurses at 7 am on days 0 (baseline), 3, and 6 of the study. After receiving chest percussion, the sputum was collected by airway suctioning of the endotracheal tube into a sterile pot.
Measurement of Respiratory System Capacity
Respiratory system capacity measurements were obtained 30 min after sputum sampling and just prior to the 7:40 am MH on days 0 (baseline), 3, and 6 of the study. The spontaneous Vt score was measured during ventilation disconnection (Haloscale Wright Respirometer; Ferraris Medical Limited; Middlesex, UK) by a respiratory therapist as spontaneous respiratory volume (milliliters) per minute divided by respiratory rate per minute. The Pimax was measured during ventilation disconnection with the inspiratory force meter by the respiratory therapist. A unidirectional expiratory valve pressure-manometer was connected to the endotracheal tube or tracheostomy, the port was occluded at end-expiration for 20 s, and after three spontaneous maximal inspiratory efforts the Pimax was recorded. 33, 34 The f/Vt score was measured during mechanical ventilation as a calculation of the ratio of the respiratory rate per minute (frequency) to the Vt setting (liters) from the display on the ventilation. A portable radiograph machine was used, and a staff radiologist reported the chest radiograph findings each morning. Scores were given as 1 (improved) or 2 (not improved).
Nurses
Oxygenation Ratio
Pao 2 /Fio 2 was measured during mechanical ventilation as derived from arterial blood gas analysis and the Fio 2 on days 0 (baseline) and 6 of the study . A calibrated blood gas analyzer (model 278; Ciba-Corning; Medfield, MA) was used for arterial blood gas analysis, and the Fio 2 was read from the display on the ventilator obtained just prior to MH.
Statistical Analysis
Statistical software (version 10.0; SPSS; Chicago, IL) was used for data analysis.
2 test and Fisher Exact Test were used to assess the success of the randomization process in achieving two comparable groups. A t test was performed to establish the baseline stability of the dependent variables. A repeated-measures analysis of variance (ANOVA) was performed to compare scores over time between the experimental and the control groups on each of the seven dependent variables measured at each of the three time points: day 0 (baseline), day 3, and day 6 of the study. This method accounted for six covariates: sex (male, female), age, setting (medical center, local hospital), intubation (endotracheotomy, endointubation), logarithm of length of ventilation prior to enrolment, and logarithm of total sputum amount. 35 The null hypothesis is that there is no interaction between group and study duration, ie, the 5 days of treatment with repeated measures on days 0, 3, and 6. There is a gradual increase in treatment effect if there is interaction between the group and the duration of the treatment. The Mantel-Haenszel 2 test for categorical data, adjusted odds ratio (OR), and multiple logistic regression were performed on the chest radiograph scores. The OR was calculated as the odds in favor of clinical improvement in the treatment group divided by the odds in favor of clinical improvement in the control group. Significance was indicated at p Ͻ 0.05.
Results
Sample
Initially, 33 patients agreed to participate in this investigation; of these, 10 patients withdrew. Twenty-three patients (n ϭ 23) completed the full course of treatment. The attrition rate in this experiment was high (30%), perhaps because of the characteristics of respiratory failure from mechanical ventilator support. Of the 10 patients who dropped out, 3 died (1 from the experimental group and 2 from the control group), 4 withdrew voluntarily (3 from the experimental group and 1 from the control group), and 3 received oxygen content Ͼ 50% during the study period (1 from the experimental group and 2 from the control group). As most of the withdrawals were for medical reasons, there is reason to hypothesize that some of these patients might have benefited from MH. In addition, there were no statistically significant differences in baseline demographics, clinical characteristics, or outcome measurements between those who withdrew and the remaining participants. Table 1 lists the sample baseline demographic and clinical characteristics including intubation, setting, and length of ventilation prior to enrollment. There were no statistically significant differences between the subjects of the two groups. The sample contained more men (n ϭ 17) than women (n ϭ 6); 74% of the subjects were Ͼ 65 years of age, 100% were married, and 74% had no history of smoking. All subjects were receiving mechanical ventilation for at least 7 days prior to study entry. The average Fio 2 was 35%; pneumonia was diagnosed in 17 persons, and lowerlobe atelectasis was found in 19 persons. Table 2 shows the actual values of the outcome variables in all patients at baseline. Differences in baseline values between the two groups were not statistically significant except for the sputum amount. The logarithm of the total sputum amount was used as covariates in the repeated-measures ANOVA model; therefore, the data from all the subjects were included in the analyses.
Patient Characteristics
Outcome Measures
Outcome measure scores are compared in Table 3 , and the mean scores and the p value for their group ϫ time interaction in repeated-measures ANOVAs adjusted for covariates are listed. The spontaneous Vt and chest radiograph scores show significant differences between the experimental and control groups, and the f/Vt and Pao 2 /Fio 2 scores show a trend toward improvement in the experimental group compared to the control group.
In the experimental group, spontaneous Vt scores of 196.3 mL at baseline increased to 270.5 mL on day 6 (indicating an improvement) compared to the control group, which increased from 208.49 mL at baseline to 220.14 mL on day 6 (p ϭ 0.035; Fig 1) . Furthermore, in the experimental group, f/Vt scores of 216.59 at baseline decreased to 150.21 on day 6 compared to the control group, which decreased from 174.04 to 164.74 (p ϭ 0.066; Fig 2) . Moreover, in the experimental group, Pao 2 /Fio 2 scores increased from 222.07 at baseline to 264.45 on day 6 compared to the control group, which decreased from 228.64 to 203.53 (p ϭ 0.061; Fig 3) . Further, in the experimental group, chest radiograph scores improved 15.55-fold (95% confidence interval, 1.14 to 239.77; p ϭ 0.040) after adjustment for covariates compared with the control group. Scores in sputum wet/dry weight ratio increased from 27.82% at baseline to 37.42% on day 6 in the experimental group and decreased from 19.29 to 18.87% in the control group; scores in sputum viscosity decreased from 9.67 min at baseline to 5.49 min on day 6 in the experimental group, and increased from 8.57 to 24.60 min in the control group, Pimax scores of 27.00 cm H 2 O at baseline increased to 36.10 cm H 2 O on day 6 in the experimental group, and decreased from 20.92 to 18.38 cm H 2 O in the control group after adjustment for covariates compared with the control group, even though these changes were not statistically significant.
Discussion
To our knowledge, this is the first study to examine the potential benefits of MH to 20 cm H 2 O by oxygen-powered, manual resuscitation bag with an inspiratory breath-hold of 3 to 5 s, while pressing half of the resuscitator, in a group of intubated patients with atelectasis. In addition, this study employed methodologic features that strengthened validity and reliability of the findings, including the randomization of subjects to groups and multivariate analysis controlling for known covariates.
Those receiving MH had statistically significant improvement in respiratory system capacity and oxygenation ratio, evidenced by the scores of spontaneous Vt and chest radiograph signs, and a trend toward improvement of f/Vt and Pao 2 /Fio 2 compared to the control groups, after adjusting for the effects of sex, age, setting, intubation, logarithm of length of ventilation prior to enrolment, and logarithm of total sputum amount. These results are not consistent with the fact that the MH technique was initially designed to enhance clearance of airway secretions. 27 Nevertheless, it supported the initial hypothesis of this study, that MH improves alveolar recruitment by delivering a larger-volume breath over time, 24 and by the development of a constant airway pressure 25 in patients with atelectasis from mechanical ventilation. In addition, MH produced no adverse events in the experimental group, as none of the patients experienced pneumothorax, suffocation, or hypotension during or following MH. However, potential limitations of this investigation should be considered when interpreting the findings. These include the following: many of the outcome measures have a subjective component to them, because the respiratory therapist who scored these outcomes was not blinded; failure to obtain outcome data of successfully weaned patients before they completed this study; length of ventilation; and the small sample size. In addition, this model did not account for cigarette consumption, length of atelectasis, and the severity of the illness, all of which could account for group differences over time. Future studies should incorporate such risk adjustment using standard severity of illness measures as APACHE (acute physiology and chronic health evaluation) 36 or sequential organ failure assessment 37 scores.
Further study on the effects of MH should be conducted using different resuscitation circuits (such as MH to 30 or 35 cm H 2 O), different subject groups (such as receiving ventilatory support for Ͻ 7 days, and differentiating between chronic and acute atelectasis), and different operators (such as physiotherapists, respiratory therapists, or nurses). Additional studies are also needed to elucidate the long-term outcomes such as time to extubation, time to discharge, ventilator-free days, and discharge status (home, long-term pulmonary care, death). Specifications by the practitioner, and patient preferences for treatment duration and frequency should also be explored.
Conclusion
This study provides evidence that MH performed in a stable patient with atelectasis associated with ventilation can improve spontaneous Vt and chest radiograph signs, and a trend toward improvement of f/Vt and Pao 2 /Fio 2 . MH is a nursing intervention that could be implemented without a physician's order, and has the potential to make a positive impact on patient outcome. While this preliminary study with a small sample size does not warrant changes in clinical practice at this time, it does contribute to the evidence base on the benefits of MH in critically ill and ventilator-dependent patients. Further investigations are required to replicate this study with a larger sample size, evaluate different techniques of MH, evaluate effects of MH in different patient groups, and determine the longterm outcomes of MH. As we continue to build evidence through additional studies, we may eventually be able to recommend practice guidelines for the procedure of MH for health professionals to treat various clinical conditions.
